Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia
- PMID: 39304825
- PMCID: PMC11414278
- DOI: 10.1186/s12902-024-01724-z
Prevalence and short-term clinical impacts of new-onset diabetes mellitus among patients with COVID-19 in jazan region, Saudi Arabia
Abstract
Background: Diabetes Mellitus is a major predictor for severity and mortality that is increased by 50% in COVID-19 infection. The aim of this study is to estimate the prevalence of new-onset DM among patients with COVID-19 and examined the short clinical outcomes of the disease.
Method: This is a retrospective study of revising electronic medical records to assess the prevalence of new-onset DM in COVID-19 patients and its impact on the severity of the disease. Adult patients with confirmed COVID-19 during the period from June 2020 to December 2021 were enrolled.
Results: 725 patients were included. 53.8% of them were males and 46.2 were females, the mean age was 43.35 ± 16.76. 13.2% were diabetics; 2.2% with preexisting DM and 11.0% had new-onset DM. 6.34% had coexisting medical conditions. DKA at presentation was observed in 6 patients (0.8%) of newly diagnosed DM. There is a significant correlation between age and family history (FH), and BMI and new-onset DM (P < 0.05). The overall mortality rate was 2.2%, and it was significantly higher in diabetics in comparison to non-diabetics (P < 0.001). 8.6% had persistent hyperglycemia after 4 months of follow-up.
Conclusion: The prevalence of COVID-19 related new-onset DM was correlated significantly with disease severity and mortality rate. Age, FH, and BMI, were the major predictors. We recommend that frequent monitoring of blood glucose for patients with COVID-19 infections to detect DM, therefore, prompt treatment can be initiated.
Keywords: COVID-19; Jazan region; New-onset DM.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Similar articles
-
Diabetes and Covid-19 among hospitalized patients in Saudi Arabia: a single-centre retrospective study.Cardiovasc Diabetol. 2020 Dec 5;19(1):205. doi: 10.1186/s12933-020-01184-4. Cardiovasc Diabetol. 2020. PMID: 33278893 Free PMC article.
-
Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.BMJ Open Diabetes Res Care. 2023 Jun;11(3):e003257. doi: 10.1136/bmjdrc-2022-003257. BMJ Open Diabetes Res Care. 2023. PMID: 37295808 Free PMC article.
-
The Association between SARS-CoV-2 Infection and Diabetic Ketoacidosis in Patients with New-Onset Diabetes: A Retrospective Study from a Diabetic Center in Saudi Arabia.Pediatr Rep. 2022 Nov 29;14(4):519-527. doi: 10.3390/pediatric14040060. Pediatr Rep. 2022. PMID: 36548203 Free PMC article.
-
Diabetes Mellitus is Associated with Severe Infection and Mortality in Patients with COVID-19: A Systematic Review and Meta-analysis.Arch Med Res. 2020 Oct;51(7):700-709. doi: 10.1016/j.arcmed.2020.07.005. Epub 2020 Aug 7. Arch Med Res. 2020. PMID: 32811670 Free PMC article.
-
COVID-19 among people with diabetes mellitus in Saudi Arabia: Current situation and new perspectives.Diabetes Metab Syndr. 2021 Sep-Oct;15(5):102231. doi: 10.1016/j.dsx.2021.102231. Epub 2021 Jul 24. Diabetes Metab Syndr. 2021. PMID: 34330072 Free PMC article. Review.
Cited by
-
Trends in diabetes mellitus prevalence and gender disparities in Jazan, Saudi Arabia: A retrospective analysis.Saudi Med J. 2025 Jun;46(6):617-623. doi: 10.15537/smj.2025.46.6.202501212. Saudi Med J. 2025. PMID: 40516935 Free PMC article.
References
-
- Zhang Jjin, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China’, Allergy: European Journal of Allergy and Clinical Immunology. Blackwell Publishing Ltd. 2020;75(7):1730–41. 10.1111/all.14238. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous